Skip to main content
OpenTrials

Clinical trial condition

Small Lymphocytic Lymphoma

Explore clinical trials studying Small Lymphocytic Lymphoma. Study availability and eligibility vary by location and protocol.

162 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Small Lymphocytic Lymphoma trial results

Completed

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

NCT01292135

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • CLL Research and Treatment Program New Hyde Park, New York, United States
  • Weill Medical College of Cornell University New York, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • New York Presbyterian Hosptial Cornell Med Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
  • Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States
View Trial Details
Completed

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00290004

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Scripps Cancer Center San Diego, California, United States
  • Northwestern University Chicago, Illinois, United States
  • The Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

NCT06970743

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking University Peoples Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 62 locations
View Trial Details

Related conditions